Patent · US Active

Compounds as nuclear transport modulators and uses thereof

US11767313B2 · kind B2 · utility

0Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2020
Grant dateSep 26, 2023
Priority date
Expiry dateJun 28, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D419/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Nuclear transport modulators are disclosed. The compounds can inhibit nuclear transporters such as the exportin-1 transporter. The compounds and pharmaceutical compositions comprising the compounds can be used to treat neurological diseases and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.